Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,581 | 97,376 | 99,271 | 141,078 | 107,954 |
| Marketable Securities | 60,046 | 126,404 | 119,487 | 72,474 | 98,417 |
| Receivables | 41,724 | 24,888 | 20,451 | 15,995 | 21,266 |
| Inventories | 26,364 | 28,680 | 34,858 | 27,278 | 31,122 |
| TOTAL | $331,799 | $311,301 | $301,021 | $270,591 | $276,297 |
| Non-Current Assets | |||||
| PPE Net | 662 | 561 | 625 | 712 | 734 |
| Intangibles | 16,250 | 16,500 | 16,750 | 17,000 | 17,250 |
| Other Non-Current Assets | 231,842 | 226,936 | 224,032 | 231,370 | 232,041 |
| TOTAL | $248,754 | $243,997 | $241,407 | $249,082 | $250,025 |
| Total Assets | $580,553 | $555,298 | $542,428 | $519,673 | $526,322 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,039 | 8,328 | 7,393 | 5,632 | 8,246 |
| Accrued Expenses | 80,512 | 69,527 | 63,317 | 44,718 | 44,667 |
| Other current liabilities | 16,077 | 16,069 | 11,484 | 11,427 | 8,193 |
| TOTAL | $100,621 | $95,955 | $84,291 | $64,212 | $63,666 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 12 | 156 | 307 |
| Other Non-Current Liabilities | 9,685 | 10,526 | 11,243 | 11,755 | 11,863 |
| TOTAL | $41,496 | $22,337 | $23,042 | $23,566 | $23,817 |
| Total Liabilities | $142,117 | $118,292 | $107,333 | $87,778 | $87,483 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,644 | 72,202 | 71,244 | 70,940 | 70,615 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -521,143 | -512,255 | -499,562 | -495,654 | -477,950 |
| Other shareholders' equity | -163 | -41 | -130 | -53 | 6 |
| TOTAL | $438,436 | $437,006 | $435,095 | $431,895 | $438,839 |
| Total Liabilities And Equity | $580,553 | $555,298 | $542,428 | $519,673 | $526,322 |